CD35 Antibody, anti-human, APC-Vio® 770, REAfinity™, 100 tests in 200 µL
文献支持

CD35 Antibody, anti-human, APC

-Vio® 770, REAfinity™, 100 tests in 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-119-514
  • 2025年12月09日
  • Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • human cell line
  • human, non-human primate
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      CD35

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REA1133

    • 标记物

      APC-Vio 770

    • 适应物种

      human, non-human primate

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 浓度

      1:50

    • 抗体英文名

      CD35 Antibody, anti-human, REAfinity™

    • 抗体名

      CD35 Antibody, anti-human, REAfinity™

    • 规格

      100 tests in 200 µL

    Identification and enumeration of CD35+ cells by flow cytometryClone REA1133 recognizes the human cell surface protein CD35, the C3b/C4b receptor, also known as CR1 or complement receptor type I. Four CD35 allotypes with different molecular weights are known; 190, 220, 250, and 280 kDa. CD35 is expressed on hematopoietic cells such as granulocytes, monocytes, B cells, subsets of NK and T cells, erythrocytes, and follicular dendritic cells (DCs). Known functions of CD35 include transport of C3 complexes on erythrocytes, complement activation, phagocytosis, and inhibition of the activation-induced proliferation of T and B cells. | Additional information: Clone REA1133 displays negligible binding to Fc receptors.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Reynes, M. et al. (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135: 2687–2694. | Klickstein, L. B. et al. (1988) Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168: 1699–1717. | Reilly, B. et al. (2010) Human peripheral CD4+ T-cells expressing complement receptor 1 (CR1, CD35). J Immunol 184 (1 Supplement): 138.3.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥4631
    苏州奕赛生物科技有限公司
    2025年07月15日询价
    ¥500
    北京百奥创新科技有限公司
    2025年05月05日询价
    ¥1090
    武汉菲恩生物科技有限公司
    2025年11月11日询价
    ¥1092
    武汉尚恩生物技术有限公司
    2025年11月18日询价
    文献支持
    CD35 Antibody, anti-human, APC-Vio® 770, REAfinity™, 100 tests in 200 µL
    询价